Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China
· Delayed Price · Currency is CNY 13.10
+0.48 (3.80%)
Mar 10, 2026, 2:15 PM CST
SHE:002675 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,406 | 10,077 | 15,115 | 13,655 | 12,659 | 15,972 | Upgrade
|
| Market Cap Growth | -6.86% | -33.33% | 10.69% | 7.87% | -20.74% | 23.59% | Upgrade
|
| Enterprise Value | 11,229 | 10,934 | 15,766 | 13,992 | 13,487 | 16,845 | Upgrade
|
| Last Close Price | 12.62 | 12.19 | 18.04 | 16.13 | 15.18 | 18.92 | Upgrade
|
| PE Ratio | 62.69 | 54.82 | 72.07 | 44.44 | 83.52 | 38.23 | Upgrade
|
| Forward PE | 32.88 | 32.62 | 35.79 | 30.39 | 28.05 | 32.24 | Upgrade
|
| PS Ratio | 3.78 | 3.51 | 4.61 | 3.81 | 3.24 | 4.67 | Upgrade
|
| PB Ratio | 1.91 | 1.88 | 2.80 | 2.59 | 2.52 | 3.22 | Upgrade
|
| P/TBV Ratio | 6.54 | 5.83 | 7.51 | 6.23 | 6.91 | 9.53 | Upgrade
|
| P/FCF Ratio | 65.86 | - | - | 22.50 | 30.62 | 51.46 | Upgrade
|
| P/OCF Ratio | 23.48 | 35.09 | 54.58 | 13.70 | 13.42 | 27.90 | Upgrade
|
| EV/Sales Ratio | 4.08 | 3.81 | 4.81 | 3.91 | 3.45 | 4.93 | Upgrade
|
| EV/EBITDA Ratio | 25.15 | 25.27 | 30.81 | 20.82 | 18.53 | 23.14 | Upgrade
|
| EV/EBIT Ratio | 40.58 | 38.69 | 42.18 | 25.36 | 22.00 | 26.95 | Upgrade
|
| EV/FCF Ratio | 71.06 | - | - | 23.05 | 32.62 | 54.27 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.17 | 0.15 | 0.13 | 0.21 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 2.04 | 2.03 | 1.52 | 1.01 | 1.44 | 1.24 | Upgrade
|
| Debt / FCF Ratio | 5.76 | - | - | 1.13 | 2.54 | 2.92 | Upgrade
|
| Net Debt / Equity Ratio | -0.05 | 0.00 | 0.02 | -0.07 | 0.02 | 0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.57 | -0.01 | 0.25 | -0.54 | 0.13 | 0.10 | Upgrade
|
| Net Debt / FCF Ratio | -1.58 | 0.03 | -0.54 | -0.60 | 0.23 | 0.23 | Upgrade
|
| Asset Turnover | 0.31 | 0.34 | 0.40 | 0.45 | 0.52 | 0.47 | Upgrade
|
| Inventory Turnover | 2.15 | 1.96 | 1.94 | 2.02 | 2.41 | 1.89 | Upgrade
|
| Quick Ratio | 1.29 | 1.06 | 0.75 | 0.83 | 0.91 | 0.98 | Upgrade
|
| Current Ratio | 1.71 | 1.46 | 1.27 | 1.33 | 1.42 | 1.55 | Upgrade
|
| Return on Equity (ROE) | 2.10% | 2.63% | 4.76% | 6.85% | 5.22% | 10.62% | Upgrade
|
| Return on Assets (ROA) | 1.93% | 2.11% | 2.87% | 4.36% | 5.09% | 5.32% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.21% | 3.35% | 5.40% | 8.71% | 8.84% | 10.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.60% | 4.10% | 6.10% | 9.50% | 10.90% | 11.40% | Upgrade
|
| Earnings Yield | 1.60% | 1.82% | 1.39% | 2.25% | 1.20% | 2.62% | Upgrade
|
| FCF Yield | 1.52% | -1.68% | -1.55% | 4.45% | 3.27% | 1.94% | Upgrade
|
| Dividend Yield | 0.48% | 0.66% | 0.69% | 0.93% | 0.99% | 1.32% | Upgrade
|
| Payout Ratio | 89.28% | 118.18% | 123.17% | 81.76% | 199.57% | 83.21% | Upgrade
|
| Buyback Yield / Dilution | -0.04% | 0.01% | -2.10% | -0.68% | -0.01% | -0.02% | Upgrade
|
| Total Shareholder Return | 0.44% | 0.66% | -1.41% | 0.25% | 0.97% | 1.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.